CHRISTOPHER W. CAIN

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ Lori Firmani, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CHRISTOPHER W. CAIN:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Director Stock Option (Right to Buy) 44.7K 04 Jun 2025 Direct
Aerovate Therapeutics, Inc. Director Stock Option (Right to Buy) 23K 29 Apr 2025 Direct
Viridian Therapeutics, Inc.\DE Director Stock Option (Right to Buy) 21K 01 Jul 2025 Indirect

Insider Reports Filed by CHRISTOPHER W. CAIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLTO Galecto, Inc. 10 Nov 2025 0 $0 3 Director 17 Nov 2025, 21:45
VRDN Viridian Therapeutics, Inc.\DE 01 Jul 2025 1 $0 4 Director 02 Jul 2025, 16:48
COGT Cogent Biosciences, Inc. 04 Jun 2025 1 $0 4 Director 05 Jun 2025, 16:24
JBIO Jade Biosciences, Inc. 29 Apr 2025 1 $0 4 Director 01 May 2025, 18:07
JBIO Jade Biosciences, Inc. 28 Apr 2025 0 $0 3 Director 01 May 2025, 17:41
VRDN Viridian Therapeutics, Inc.\DE 10 Mar 2025 1 $0 4 Director 12 Mar 2025, 16:19
VRDN Viridian Therapeutics, Inc.\DE 10 Mar 2025 0 $0 3 Director 12 Mar 2025, 16:17
COGT Cogent Biosciences, Inc. 05 Jun 2024 1 $0 4 Director 13 Jun 2024, 19:18
COGT Cogent Biosciences, Inc. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:52
COGT Cogent Biosciences, Inc. 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 17:09